​
​

Spyre Therapeutics Ownership | Who Owns Spyre Therapeutics?

OverviewForecastRevenueFinancialsChart

Spyre Therapeutics Ownership Summary

Spyre Therapeutics is owned by 42.02% institutional investors, and 57.98% retail investors. Fmr is the largest institutional shareholder, holding 16.82% of SYRE shares.

SYRE Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSpyre Therapeutics42.02%-57.98%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Recent Insider Transactions

DateNameRoleActivityValue
Nov 06, 2024Albers Jeffrey W.-Sell$246.31K
Oct 25, 2024Albers Jeffrey W.-Sell$10.93K
Sep 03, 2024Burrows Scott L Chief Financial OfficerSell$522.07K

Insider Transactions Trends

DateBuySell
2024 Q4-2
2024 Q3-1
2024 Q2--
2024 Q1--
2023 Q4--

SYRE Ownership FAQ

Who Owns Spyre Therapeutics?

Spyre Therapeutics shareholders are primarily institutional investors at 42.02%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Spyre Therapeutics's industry, Biotech Stocks , is 45.35%, which Spyre Therapeutics falls below.

Who owns the most shares of Spyre Therapeutics?

Spyre Therapeutics’s largest shareholders are Fmr (7.62M shares, 16.82%), Fairmount funds management (4.02M shares, 8.87%), and Rtw investments, lp (3.26M shares, 7.19%). Together, they hold 32.88% of Spyre Therapeutics’s total shares outstanding.

Does Blackrock own Spyre Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Spyre Therapeutics.

Who is Spyre Therapeutics’s biggest shareholder by percentage of total assets invested?

Fairmount funds management is Spyre Therapeutics’s biggest shareholder by percentage of total assets invested, with 9.58% of its assets in 4.02M Spyre Therapeutics shares, valued at 118.17M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools